MedPath

Health-related Quality of Life in Rare Kidney Stone

Completed
Conditions
Cystinuria
Primary Hyperoxaluria
Adenine Phosphoribosyl Transferase Deficiency
Dent Disease
Interventions
Other: Health-related Quality of Life in Rare Kidney Stone Questionnaire
Registration Number
NCT02124395
Lead Sponsor
NYU Langone Health
Brief Summary

Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium

Detailed Description

The purpose of this study is to learn about Health-related Quality Of Life (HRQoL) in patients enrolled in the Rare Kidney Stone Consortium (RKSC) registries. Quality of life studies look at different aspects of both physical and mental components of people's lives. HRQoL data for people affected by kidney stones are not currently available for people followed over time.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
365
Inclusion Criteria
  • Qualify to participate in one of the Rare Kidney Stone Registries.
  • Be at least 5 years old (for SF-10)
  • Are able to communicate using the English language
  • Consent to participate in the study (or "assent" if under 18 years old)
  • Have internet access with an email account or a valid home address
Read More
Exclusion Criteria

None, if inclusion criteria are met

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
APRT deficiencyHealth-related Quality of Life in Rare Kidney Stone QuestionnaireAll rare kidney stone patients enrolled in RKSC registries that are able to communicate using the English language, are able to consent to participation in the study, have internet access with an email account and/or a valid address and are at minimum 5 years of age (for SF-10)
Primary HyperoxaluriaHealth-related Quality of Life in Rare Kidney Stone QuestionnaireAll rare kidney stone patients enrolled in RKSC registries that are able to communicate using the English language, are able to consent to participation in the study, have internet access with an email account and/or a valid address and are at minimum 5 years of age (for SF-10)
CystinuriaHealth-related Quality of Life in Rare Kidney Stone QuestionnaireAll rare kidney stone patients enrolled in RKSC registries that are able to communicate using the English language, are able to consent to participation in the study, have internet access with an email account and/or a valid address and are at minimum 5 years of age (for SF-10)
Dent DiseaseHealth-related Quality of Life in Rare Kidney Stone QuestionnaireAll rare kidney stone patients enrolled in RKSC registries that are able to communicate using the English language, are able to consent to participation in the study, have internet access with an email account and/or a valid address and are at minimum 5 years of age (for SF-10)
Primary Outcome Measures
NameTimeMethod
Assessment of HRQoL in patients with rare kidney stonesOnce a year for up to 5 years after signed consent

Assessment of HRQoL in patients with rare kidney stones. Comparison of HRQoL results between rare kidney stone formers, general population and other populations with relevant chronic diseases

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Primary Hyperoxaluria and Dent Disease Registry - Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

New York University School of Medicine - Cystinuria Registry

🇺🇸

New York, New York, United States

APRT Registry - Landspitali Universtiy Hospital

🇮🇸

Reykjavik, Iceland

© Copyright 2025. All Rights Reserved by MedPath